Although LINC00221 remains unreported in HCC contexts, its functionality may parallel lncRNA ZFAS1, which mediates donafenib resistance through LSD1/CoREST/p65 axis activation (Hou et al., 2024). The gene discussed is ZFAS1; the disease is hepatocellular carcinoma.